Literature DB >> 11585716

Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics.

S Moritz1, B Andresen, D Jacobsen, K Mersmann, U Wilke, M Lambert, D Naber, M Krausz.   

Abstract

There is widespread evidence that schizophrenic symptomatology is best represented by three syndromes (positive, negative, disorganized). Both the disorganized and negative syndrome have been found to correlate with several neurocognitive dysfunctions. However, previous studies investigated samples predominantly treated with typical neuroleptics, which frequently induce parkinsonian symptoms that are hard to disentangle from primary negative symptoms and may have inflated correlations with neurocognition. A newly developed psychopathological instrument called the Positive and Negative and Disorganized Symptoms Scale (PANADSS) was evaluated in 60 schizophrenic patients. Forty-seven participants treated with atypical neuroleptics performed several neurocognitive tasks.A three-factor solution of schizophrenic symptomatology emerged. Negative symptomatology was associated with diminished creative verbal fluency and digit span backward, whereas disorganization was significantly correlated with impaired Stroop, WCST and Trail-Making Test B performance.Data suggest that disorganization is associated with tasks that demand executive functioning. Previous findings reporting correlations between negative symptomatology and neurocognition may have been confounded by the adverse consequences of typical neuroleptics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585716     DOI: 10.1016/s0924-9338(01)00591-0

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  7 in total

1.  Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.

Authors:  Tanja Veselinović; Holger Schorn; Ingo Vernaleken; Katharina Schiffl; Christoph Hiemke; Gerald Zernig; Ruben Gur; Gerhard Gründer
Journal:  Psychopharmacology (Berl)       Date:  2011-06-04       Impact factor: 4.530

Review 2.  Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review.

Authors:  Natascha Wilson; Jean Lud Cadet
Journal:  J Addict Dis       Date:  2009-10

3.  Cognitive functioning and negative symptoms in first episode schizophrenia: different patterns of correlates.

Authors:  José Manuel Rodríguez-Sánchez; Benedicto Crespo-Facorro; César González-Blanch; Rocío Pérez-Iglesias; Mario Alvarez-Jiménez; Obdulia Martínez; José Luis Vázquez-Barquero
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

4.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

5.  Neurocognitive pattern analysis reveals classificatory hierarchy of attention deficits in schizophrenia.

Authors:  Christina Shen; Florin C Popescu; Eric Hahn; Tam T M Ta; Michael Dettling; Andres H Neuhaus
Journal:  Schizophr Bull       Date:  2013-08-10       Impact factor: 9.306

Review 6.  Exploring the associations of herpes simplex virus infection and cognitive dysfunction in schizophrenia: Studies in India.

Authors:  Smita Neelkanth Deshpande; Vishwajit Laxmikant Nimgaonkar
Journal:  Indian J Psychiatry       Date:  2018 Oct-Dec       Impact factor: 1.759

7.  On the Complexity of Brain Disorders: A Symptom-Based Approach.

Authors:  Ahmed A Moustafa; Joseph Phillips; Szabolcs Kéri; Blazej Misiak; Dorota Frydecka
Journal:  Front Comput Neurosci       Date:  2016-02-23       Impact factor: 2.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.